Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 31, 2015 7:29 AM ET

Biotechnology

Company Overview of Argos Therapeutics, Inc.

Executive Profile

Alexey Vinogradov Ph.D.

Chief Business Officer and Managing Partner, Inbio Ventures
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
41--

Background

Mr. Alexey Vinogradov, Ph.D., has been a Managing Partner and of CJSC Kollektsiya, or Inbio Ventures since 2012. Prior to joining Inbio Ventures, from 2009 to 2012, Mr. Vinogradov served as Investment Manager at Bioprocess Capital Partners. From 2004 to 2009, he was employed by the International Science and Technology Center, where he provided consulting and investment support to early-stage biotechnology companies. From 2002 to 2004, he was employed by Core-Biotech, ...

Corporate Headquarters

4233 Technology Drive
Durham, North Carolina 27704

United States

Phone: 919-287-6300
Fax: --

Board Members Memberships

2014-Present
Director

Education

PhD
Lomonosov Moscow State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Argos Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.